Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
29.87
-0.34 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
29.83
-0.13%
After-hours: Aug 15, 2025, 07:19 PM EDT

Amphastar Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
134.71M 141.63M 159.52M 157.72M 166.51M 154.69M 137.54M 135.29M 101.94M 93.17M 91.39M 77.23M 92.32M 83.59M 63.3M 37.75M 11.58M 1.53M
Depreciation & Amortization
38.78M 39.91M 38.67M 37.79M 55.47M 48.34M 41.78M 35.42M 29.34M 29.34M 28.74M 27.86M 26.88M 26.72M 26.75M 26.97M 27.13M 26.18M
Stock-Based Compensation
26M 25.4M 24.37M 23.36M 22.41M 21.49M 20.24M 19.92M 19.58M 18.95M 17.86M 17.41M 17.03M 18.88M 18.69M 19.17M 19.62M 20.05M
Other Working Capital
-22M -5.63M -7.64M -50.76M -20.93M -10.68M -7.72M 21.8M 469K -23.2M -24.36M -19.89M -11.16M 8.04M 4.93M -2.89M -5.39M -6.96M
Other Non-Cash Items
11.32M 10.23M 5.38M 34.63M 14.5M 8.91M 11.83M 2.4M 110K -8.25M -11.54M -10.5M -27.01M -15.35M -13.03M -13.17M 524K 232K
Deferred Income Tax
n/a n/a n/a -12.58M -15.17M -3.68M -3.68M -6.86M -4.26M -15.75M -15.75M -961K 4.21M 4.21M 4.21M 2.65M -515K -515K
Change in Working Capital
-51.16M -24M -14.55M -32.7M -31.12M -31.34M -24.21M -11.32M -15.81M -49.32M -32.18M -7.3M -27.49M 7.88M -1.92M 1.07M 22.34M 31.13M
Operating Cash Flow
159.66M 193.17M 213.39M 208.23M 212.6M 198.41M 183.5M 174.87M 130.91M 78.8M 89.18M 114.4M 96.59M 125.93M 97.99M 74.45M 80.68M 78.61M
Capital Expenditures
-47.47M -42.95M -41.04M -38.07M -34.47M -37.48M -38.17M -35.03M -30.46M -27.37M -24.03M -24.6M -26.2M -25.98M -27.46M -29.91M -28.32M -33.47M
Cash Acquisitions
129M n/a n/a 506.41M 371.83M n/a n/a -506.41M -500.83M 421K 421K 421K 421K n/a n/a n/a n/a n/a
Purchase of Investments
-70.86M -61.4M -76.79M -139.26M -146.33M -156.49M -144.56M -57.99M -43.53M -41.02M -35.76M -35.48M -22.14M -18.19M -17.38M -26.02M -20.8M -18.06M
Sales Maturities Of Investments
64.07M 106.81M 126.02M 118.36M 126.75M 72.06M 38.62M 51.3M 46.73M 39.5M 27.97M 16.81M 16.69M 17.36M 18.77M 28.87M 20.22M 15.69M
Other Investing Acitivies
-135.15M -132.16M -133.12M -639.73M -506.64M -505.63M -505.02M 1.83M -2.31M -1.53M -1.37M -1.65M -1.78M -2.28M -2.61M -1.84M -1.68M -549K
Investing Cash Flow
-60.41M -129.69M -124.93M -192.3M -188.87M -627.55M -649.12M -546.3M -530.4M -30M -32.78M -44.5M -33.01M -29.09M -28.67M -28.89M -30.58M -36.39M
Debt Repayment
19.66M 7.79M 10.17M -44.73M 90.72M 531.29M 526.34M 576.37M 430.92M -2.21M -1.78M -2.27M 39.01M 33.56M 32.1M 34.02M -8.42M -3.62M
Common Stock Repurchased
-76.96M -96.46M -102.77M -60.77M -75.81M -67.44M -58.14M -76.21M -40.71M -46.7M -39.91M -35.28M -26.88M -26.32M -28.87M -18.83M -17.06M -17.26M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.66M 976K 5.83M 1.93M -9.05M -23.2M -27.52M -24.99M -15.6M 4.27M 15.25M 18.57M -33.67M -33.83M -41.1M -44.6M 9.55M 22.2M
Financial Cash Flow
-101.36M -81.88M -80.95M -94.19M 15.23M 454.06M 454.09M 485.01M 384.47M -44.63M -26.44M -18.97M -21.53M -25.73M -37.02M -28.55M -15.08M 2.56M
Net Cash Flow
-1.93M -18.37M 7.31M -78.69M 38.57M 24.53M -11.8M 113.56M -15.11M 3.99M 29.75M 50.63M 41.8M 71.03M 32.08M 17.07M 35.34M 45.13M
Free Cash Flow
112.19M 150.23M 172.34M 170.15M 178.13M 160.93M 145.34M 139.83M 100.44M 51.43M 65.15M 89.79M 70.39M 99.96M 70.54M 44.54M 52.37M 45.15M